Omega Healthcare Investors, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
624.00
420.00
255.00
436.00
416.00
162.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-2.00
32.00
-15.00
-45.00
-94.00
-30.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
891.00
750.00
626.00
629.00
740.00
714.00
Cash Flow from Investing Activities
-552.00
-671.00
-9.00
439.00
-542.00
-95.00
Cash Flow from Financing Activities
-838.00
25.00
-473.00
-789.00
-341.00
-485.00
Net Cash Inflow / Outflow
-494.00
104.00
144.00
276.00
-143.00
134.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
5.00
0.00
0.00
-2.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Omega Healthcare Investors, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
624.433
-135.733
759.00
560.05%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-2.948
-52.662
50.00
94.40%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
891.464
359.641
532.00
147.88%
Cash Flow from Investing Activities
-552.705
-658.001
106.00
16.00%
Cash Flow from Financing Activities
-838.256
383.256
-1,221.00
-318.72%
Net Cash Inflow / Outflow
-494.172
89.211
-583.00
-653.94%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
5.325
4.315
1.00
23.41%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 18.79% vs 19.78% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
891.46
750.45
18.79%






